Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway.
- DOI
- 10.1016/j.ejphar.2026.179512
- Published
- 2026 Nov 4
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179512,
title = {Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway.},
author = {Zhou J and Wang R and Yao R and Liu F and Yuan Y},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179512},
url = {https://doi.org/10.1016/j.ejphar.2026.179512}
}RIS
TY - JOUR TI - Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway. AU - Zhou J AU - Wang R AU - Yao R AU - Liu F AU - Yuan Y PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179512 UR - https://doi.org/10.1016/j.ejphar.2026.179512 ER -
APA
J, Z., R, W., R, Y., F, L., & Y, Y. (2026). Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179512
Source records
- pubmed · retrieved 2026-11-10T11:09:49.196Z